Table of Content

1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Assumptions
1.4. Market Segmentation

2. Preface

3. Executive Summary

4. Impact of COVID-19 on Global COVID-19 Vaccine Market

5. Global COVID-19 Vaccine Market Government Regulations

6. Global COVID-19 Vaccine Market Trends & Insights

7. Global COVID-19 Vaccine Market Dynamics
7.1. Growth Drivers
7.2. Challenges
7.3. Impact Analysis

8. Global COVID-19 Vaccine Market Hotspot & Opportunities

9. Global COVID-19 Vaccine Market Analysis 2021-2026F
9.1. Market Size & Analysis
9.1.1. Market Revenue
9.2. Market Share & Analysis
9.2.1. By Vaccine Type
9.2.1.1. Whole-microbe COVID-19 Vaccine
9.2.1.1.1. Inactivated COVID-19 Vaccine
9.2.1.1.2. Live Attenuated COVID-19 Vaccine
9.2.1.1.3. Viral Vector-Based COVID-19 Vaccine
9.2.1.2. Protein Subunit COVID-19 Vaccine
9.2.1.3. Genetic Approach (Nucleic Acid Vaccine)
9.2.2. By Patient Class
9.2.2.1. Senior Citizens
9.2.2.2. Adults
9.2.2.3. Paediatrics
9.2.3. By End User
9.2.3.1. Academic & Research Institutes
9.2.3.2. Vaccination Centres
9.2.3.3. Clinics
9.2.3.4. Hospitals
9.2.3.5. Others
9.2.4. By Region
9.2.4.1. North America
9.2.4.2. South America
9.2.4.3. Europe
9.2.4.4. Africa
9.2.4.5. Middle East
9.2.4.6. Asia Pacific

10. North America COVID-19 Vaccine Market Outlook, 2021-2026F
10.1. Market Size & Analysis
10.1.1. Market Revenue
10.2. Market Share & Analysis
10.2.1. By Vaccine Type
10.2.2. By Patient Class
10.2.3. By End Users
10.2.4. By Country
10.2.4.1. The US COVID-19 Vaccine Market Outlook, 2021-2026F
10.2.4.1.1. Market Size & Analysis
10.2.4.1.1.1. Market Revenue
10.2.4.1.2. Market Share & Analysis
10.2.4.1.2.1. By Vaccine Type
10.2.4.1.2.2. By Patient Class
10.2.4.1.2.3. By End User
10.2.4.2. Canada COVID-19 Vaccine Market Outlook, 2021-2026F
10.2.4.2.1. Market Size & Analysis
10.2.4.2.1.1. Market Revenue
10.2.4.2.2. Market Share & Analysis
10.2.4.2.2.1. By Vaccine Type
10.2.4.2.2.2. By Patient Class
10.2.4.2.2.3. By End User
10.2.4.3. Mexico COVID-19 Vaccine Market Outlook, 2021-2026F
10.2.4.3.1. Market Size & Analysis
10.2.4.3.1.1. Market Revenue
10.2.4.3.2. Market Share & Analysis
10.2.4.3.2.1. By Vaccine Type
10.2.4.3.2.2. By Patient Class
10.2.4.3.2.3. By End User

11. South America COVID-19 Vaccine Market Outlook, 2021-2026F
11.1. Market Size & Analysis
11.1.1. Market Revenue
11.2. Market Share & Analysis
11.2.1. By Vaccine Type
11.2.2. By Patient Class
11.2.3. By End Users
11.2.4. By Country
11.2.4.1. Brazil COVID-19 Vaccine Market Outlook, 2021-2026F
11.2.4.1.1. Market Size & Analysis
11.2.4.1.1.1. Market Revenue
11.2.4.1.2. Market Share & Analysis
11.2.4.1.2.1. By Vaccine Type
11.2.4.1.2.2. By Patient Class
11.2.4.1.2.3. By End User
11.2.4.2. Rest of South America COVID-19 Vaccine Market Outlook, 2021-2026F
11.2.4.2.1. Market Size & Analysis
11.2.4.2.1.1. Market Revenue
11.2.4.2.2. Market Share & Analysis
11.2.4.2.2.1. By Vaccine Type
11.2.4.2.2.2. By Patient Class
11.2.4.2.2.3. By End User

12. Europe COVID-19 Vaccine Market Outlook, 2021-2026F
12.1. Market Size & Analysis
12.1.1. Market Revenue
12.2. Market Share & Analysis
12.2.1. By Vaccine Type
12.2.2. By Patient Class
12.2.3. By End Users
12.2.4. By Country
12.2.4.1. UK COVID-19 Vaccine Market Outlook, 2021-2026F
12.2.4.1.1. Market Size & Analysis
12.2.4.1.1.1. Market Revenue
12.2.4.1.2. Market Share & Analysis
12.2.4.1.2.1. By Vaccine Type
12.2.4.1.2.2. By Patient Class
12.2.4.1.2.3. By End User
12.2.4.2. Germany COVID-19 Vaccine Market Outlook, 2021-2026F
12.2.4.2.1. Market Size & Analysis
12.2.4.2.1.1. Market Revenue
12.2.4.2.2. Market Share & Analysis
12.2.4.2.2.1. By Vaccine Type
12.2.4.2.2.2. By Patient Class
12.2.4.2.2.3. By End User
12.2.4.3. France COVID-19 Vaccine Market Outlook, 2021-2026F
12.2.4.3.1. Market Size & Analysis
12.2.4.3.1.1. Market Revenue
12.2.4.3.2. Market Share & Analysis
12.2.4.3.2.1. By Vaccine Type
12.2.4.3.2.2. By Patient Class
12.2.4.3.2.3. By End User
12.2.4.4. Italy COVID-19 Vaccine Market Outlook, 2021-2026F
12.2.4.4.1. Market Size & Analysis
12.2.4.4.1.1. Market Revenue
12.2.4.4.2. Market Share & Analysis
12.2.4.4.2.1. By Vaccine Type
12.2.4.4.2.2. By Patient Class
12.2.4.4.2.3. By End User
12.2.4.5. Spain COVID-19 Vaccine Market Outlook, 2021-2026F
12.2.4.5.1. Market Size & Analysis
12.2.4.5.1.1. Market Revenue
12.2.4.5.2. Market Share & Analysis
12.2.4.5.2.1. By Vaccine Type
12.2.4.5.2.2. By Patient Class
12.2.4.5.2.3. By End User
12.2.4.6. Russia COVID-19 Vaccine Market Outlook, 2021-2026F
12.2.4.6.1. Market Size & Analysis
12.2.4.6.1.1. Market Revenue
12.2.4.6.2. Market Share & Analysis
12.2.4.6.2.1. By Vaccine Type
12.2.4.6.2.2. By Patient Class
12.2.4.6.2.3. By End User
12.2.4.7. Rest of Europe COVID-19 Vaccine Market Outlook, 2021-2026F
12.2.4.7.1. Market Size & Analysis
12.2.4.7.1.1. Market Revenue
12.2.4.7.2. Market Share & Analysis
12.2.4.7.2.1. By Vaccine Type
12.2.4.7.2.2. By Patient Class
12.2.4.7.2.3. By End User

13. Middle East & Africa COVID-19 Vaccine Market Outlook, 2021-2026F
13.1. Market Size & Analysis
13.1.1. Market Revenue
13.2. Market Share & Analysis
13.2.1. By Vaccine Type
13.2.2. By Patient Class
13.2.3. By End Users
13.2.4. By Country
13.2.4.1. GCC COVID-19 Vaccine Market Outlook, 2021-2026F
13.2.4.1.1. Market Size & Analysis
13.2.4.1.1.1. Market Revenue
13.2.4.1.2. Market Share & Analysis
13.2.4.1.2.1. By Vaccine Type
13.2.4.1.2.2. By Patient Class
13.2.4.1.2.3. By End User
13.2.4.2. South Africa COVID-19 Vaccine Market Outlook, 2021-2026F
13.2.4.2.1. Market Size & Analysis
13.2.4.2.1.1. Market Revenue
13.2.4.2.2. Market Share & Analysis
13.2.4.2.2.1. By Vaccine Type
13.2.4.2.2.2. By Patient Class
13.2.4.2.2.3. By End User

14. Asia Pacific COVID-19 Vaccine Market Outlook, 2021-2026F
14.1. Market Size & Analysis
14.1.1. Market Revenue
14.2. Market Share & Analysis
14.2.1. By Vaccine Type
14.2.2. By Patient Class
14.2.3. By End Users
14.2.4. By Country
14.2.4.1. India COVID-19 Vaccine Market Outlook, 2021-2026F
14.2.4.1.1. Market Size & Analysis
14.2.4.1.1.1. Market Revenue
14.2.4.1.2. Market Share & Analysis
14.2.4.1.2.1. By Vaccine Type
14.2.4.1.2.2. By Patient Class
14.2.4.1.2.3. By End User
14.2.4.2. China COVID-19 Vaccine Market Outlook, 2021-2026F
14.2.4.2.1. Market Size & Analysis
14.2.4.2.1.1. Market Revenue
14.2.4.2.2. Market Share & Analysis
14.2.4.2.2.1. By Vaccine Type
14.2.4.2.2.2. By Patient Class
14.2.4.2.2.3. By End User
14.2.4.3. Japan COVID-19 Vaccine Market Outlook, 2021-2026F
14.2.4.3.1. Market Size & Analysis
14.2.4.3.1.1. Market Revenue
14.2.4.3.2. Market Share & Analysis
14.2.4.3.2.1. By Vaccine Type
14.2.4.3.2.2. By Patient Class
14.2.4.3.2.3. By End User
14.2.4.4. South Korea COVID-19 Vaccine Market Outlook, 2021-2026F
14.2.4.4.1. Market Size & Analysis
14.2.4.4.1.1. Market Revenue
14.2.4.4.2. Market Share & Analysis
14.2.4.4.2.1. By Vaccine Type
14.2.4.4.2.2. By Patient Class
14.2.4.4.2.3. By End User
14.2.4.5. Rest of Asia Pacific COVID-19 Vaccine Market Outlook, 2021-2026F
14.2.4.5.1. Market Size & Analysis
14.2.4.5.1.1. Market Revenue
14.2.4.5.2. Market Share & Analysis
14.2.4.5.2.1. By Vaccine Type
14.2.4.5.2.2. By Patient Class
14.2.4.5.2.3. By End User
15. Global COVID-19 Vaccine Market Key Strategic Imperatives for Success & Growth
16. Competition Outlook
16.1. Competition Matrix
16.2. Company Profiles (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
16.2.1. AstraZeneca Plc
16.2.2. Johnson & Johnson Inc.
16.2.3. Novavax
16.2.4. BioNTech
16.2.5. Moderna
16.2.6. Glaxo Smith Kline Plc
16.2.7. CSL Ltd.
16.2.8. Abbott Laboratories
16.2.9. Daiichi Sankyo Company Ltd
16.2.10. Astellas Pharma Inc.
16.2.11. Pfizer
16.2.12. Bharat Biotech
16.2.13. Serum Institute of India
17. Disclaimer